ArticleCancer2018
The cost and cost-effectiveness of childhood cancer treatment in El Salvador, Central America: A report from the Childhood Cancer 2030 Network.
Article in Cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America.Applied health economics and health policy · 2023Pooled it
- Cost and cost-effectiveness of childhood cancer treatment in low-income and middle-income countries: a systematic review.BMJ global health · 2019Pooled it
- Global, regional, and National burden of childhood leukemia from 1990 to 2021.BMC pediatrics · 2025Article
- Comprehensive health status and health-related quality of life of children at diagnosis of high-risk neuroblastoma: a multicentric pilot study.Hematology, transfusion and cell therapy · 2024Article
- Primary health care as a tool to promote equity and sustainability; a review of Latin American and Caribbean literature.International journal for equity in health · 2024Review
- Determining the cost and cost-effectiveness of childhood cancer treatment in Haiti.Ecancermedicalscience · 2024Article
- Article
- Cost-effectiveness of childhood cancer treatment in Egypt: Lessons to promote high-value care in a resource-limited setting based on real-world evidence.EClinicalMedicine · 2023Article
- Cost and Cost-Effectiveness of Treating Childhood Cancer at Jimma Medical Center.ClinicoEconomics and outcomes research : CEOR · 2023Article
- Developing and sustaining high-quality care for children with cancer: the WHO Global Initiative for Childhood Cancer.Revista panamericana de salud publica = Pan American journal of public health · 2023Article
- Assessing the cost and economic impact of tertiary-level pediatric cancer care in Tanzania.PloS one · 2022Article
- Parent Engagement and Agency in Latin American Childhood Cancer Treatment: A Qualitative Investigation.JCO global oncology · 2020Article
- Health system determinants of access to essential medicines for children with cancer in Ghana.BMJ global health · 2020Article
- Economics of Pediatric Cancer in Four Eastern Mediterranean Countries: A Comparative Assessment.JCO global oncology · 2020Review
- The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017.The Lancet. Oncology · 2019Article
- Costing Methods Applied to Cancer.Journal of global oncology · 2019Article
- Political priority and pathways to scale-up of childhood cancer care in five nations.PloS one · 2019Article
- Evidence From Ghana Indicates That Childhood Cancer Treatment in Sub-Saharan Africa Is Very Cost Effective: A Report From the Childhood Cancer 2030 Network.Journal of global oncology · 2018Article
- Global efforts toward the cure of childhood acute lymphoblastic leukaemia.The Lancet. Child & adolescent health · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundAlthough previous studies have examined the cost of treating individual childhood cancers in low-income and middle-income countries, to the authors' knowledge none has examined the overall cost and cost-effectiveness of operating a childhood cancer treatment center. Herein, the authors examined the cost and sources of financing of a pediatric cancer unit in Hospital Nacional de Ninos Benjamin Bloom in El Salvador, and make estimates of cost-effectiveness.
methodsAdministrative data regarding costs and volumes of inputs were obtained for 2016 for the pediatric cancer unit. Similar cost and volume data were obtained for shared medical services provided centrally (eg, blood bank). Costs of central nonmedical support services (eg, utilities) were obtained from hospital data and attributed by inpatient share. Administrative data also were used for sources of financing. Cost-effectiveness was estimated based on the number of new patients diagnosed annually and survival rates.
resultsThe pediatric cancer unit cost $5.2 million to operate in 2016 (treating 90 outpatients per day and experiencing 1385 inpatient stays per year). Approximately three-quarters of the cost (74.7%) was attributed to 4 items: personnel (21.6%), pathological diagnosis (11.5%), pharmacy (chemotherapy, supportive care medications, and nutrition; 31.8%), and blood products (9.8%). Funding sources included government (52.5%), charitable foundations (44.2%), and a social security contribution scheme (3.4%). Based on 181 new patients per year and a 5-year survival rate of 48.5%, the cost per disability-adjusted life-year averted was $1624, which is under the threshold considered to be very cost effective.
conclusionsTreating childhood cancer in a specialized unit in low-income and middle-income countries can be done cost-effectively. Strong support from charitable foundations aids with affordability. Cancer 2018;124:391-7. © 2017 American Cancer Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.